Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs
(Reuters) - Eli Lilly has entered into a settlement deal with a medi spa that had sold counterfeit versions of its popular di...
May 14, 2024
Activist Jana Partners built position in QuidelOrtho in first quarter, sources say
By Svea Herbst-Bayliss (Reuters) - Activist investor Jana Partners built a new stake in U.S. diagnostics company QuidelOrtho ...
May 14, 2024
Grifols swings to profit, says debt reduction on track
By Joan Faus BARCELONA (Reuters) - Spanish drugmaker Grifols swung to a first-quarter net profit of 21 million euros ($23 mil...
May 14, 2024
CDC makes public influenza A wastewater data to assist bird flu probe
(Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday released data on influenza A found in wastew...
May 14, 2024
US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine
(Reuters) - The U.S. Food and Drug Administration has declined to approve the expanded use of Dynavax Technologies' hepatitis...
May 14, 2024
Bayer's Q1 adjusted profit beats analyst consensus
FRANKFURT (Reuters) - Bayer on Tuesday reported a 1.3% decline in adjusted earnings in the first quarter, beating analysts' f...
May 14, 2024
Wegovy weight loss sustained for four years in trial, Novo Nordisk says
By Maggie Fick LONDON (Reuters) - Patients taking Novo Nordisk's popular Wegovy obesity treatment maintained an average of 10...
May 14, 2024
US reclassification could drive fresh research funding into pot sector
By Mrinalika Roy (Reuters) - The U.S. pot sector could see an influx of medical research funding from healthcare investors am...
May 13, 2024
Denmark faces Wegovy shortage due to rising demand, medicines agency says
COPENHAGEN (Reuters) -The Danish medicines agency on Monday warned of a supply shortage for two separate doses of Novo Nordis...
May 13, 2024
Edwards Lifesciences hit with Meril's EU antitrust complaint
By Foo Yun Chee BRUSSELS (Reuters) - U.S. heart valve maker Edwards Lifesciences has been hit with an EU antitrust complaint ...
May 13, 2024